Search alternatives:
clause processing » cheese processing (Expand search), sausage processing (Expand search), vinasse processing (Expand search)
decrease clause » release clause (Expand search), decrease release (Expand search)
costs decrease » loss decrease (Expand search), not decrease (Expand search), cells decrease (Expand search)
decrease treg » decrease the (Expand search), increase treg (Expand search), decrease their (Expand search)
treg decrease » the decrease (Expand search), urea decrease (Expand search), drugs decrease (Expand search)
disease costs » disease cost (Expand search), disease cross (Expand search), disease cases (Expand search)
clause processing » cheese processing (Expand search), sausage processing (Expand search), vinasse processing (Expand search)
decrease clause » release clause (Expand search), decrease release (Expand search)
costs decrease » loss decrease (Expand search), not decrease (Expand search), cells decrease (Expand search)
decrease treg » decrease the (Expand search), increase treg (Expand search), decrease their (Expand search)
treg decrease » the decrease (Expand search), urea decrease (Expand search), drugs decrease (Expand search)
disease costs » disease cost (Expand search), disease cross (Expand search), disease cases (Expand search)
1
3
4
“... incorporates the natural history, costs and quality of life of all the tobacco-related adult-specific diseases...”
Access document
Access document
Article
5
“.... To describe, as disease progresses, how it is like to care for a PwD in a familial context and the costs...”
Access document
Access document
6
8
9
10
11
12
“...Objective: to evaluate the costs of hospitalizations for ambulatory care sensitive conditions...”
Access document
Access document
Article
13
“... of hospitalization decrease with increasing age. 70.6% of total expenditures (R$ 71,480,950.14) were for circulatory...”
Access document
Access document
Article
14
15
16
“...Parkinson's disease (PD) is a common disorder that causes a marked decrease in the quality of life...”
Access document
Access document
Article
17
18
“... to increase targeted driven therapy and decrease adverse events and their costs....”
Access document
Access document
Article
19
20